Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.

Veljkovic V, Goeijenbier M, Glisic S, Veljkovic N, Perovic VR, Sencanski M, Branch DR, Paessler S.

F1000Res. 2015 May 1;4:104. doi: 10.12688/f1000research.6436.1. eCollection 2015.

2.

Improving attrition rates in Ebola virus drug discovery.

Glisic S, Paessler S, Veljkovic N, Perovic VR, Prljic J, Veljkovic V.

Expert Opin Drug Discov. 2015 Jun 30:1-8. [Epub ahead of print]

PMID:
26125997
3.

In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Veljkovic V, Glisic S, Muller CP, Scotch M, Branch DR, Perovic VR, Sencanski M, Veljkovic N, Colombatti A.

Front Microbiol. 2015 Feb 19;6:135. doi: 10.3389/fmicb.2015.00135. eCollection 2015.

4.

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.

Veljkovic V, Loiseau PM, Figadere B, Glisic S, Veljkovic N, Perovic VR, Cavanaugh DP, Branch DR.

F1000Res. 2015 Feb 2;4:34. doi: 10.12688/f1000research.6110.1. eCollection 2015.

5.

Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Nov 12;32(48):6569-75. doi: 10.1016/j.vaccine.2014.07.007. Epub 2014 Jul 19.

PMID:
25045818
6.

Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.

Ristic B, Bosnjak M, Arsikin K, Mircic A, Suzin-Zivkovic V, Bogdanovic A, Perovic V, Martinovic T, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V, Harhaji-Trajkovic L.

Exp Cell Res. 2014 Aug 1;326(1):90-102. doi: 10.1016/j.yexcr.2014.05.021. Epub 2014 Jun 5.

PMID:
24907655
7.

Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death.

Bosnjak M, Ristic B, Arsikin K, Mircic A, Suzin-Zivkovic V, Perovic V, Bogdanovic A, Paunovic V, Markovic I, Bumbasirevic V, Trajkovic V, Harhaji-Trajkovic L.

PLoS One. 2014 Apr 8;9(4):e94374. doi: 10.1371/journal.pone.0094374. eCollection 2014.

8.

Feature-based classification of amino acid substitutions outside conserved functional protein domains.

Gemovic B, Perovic V, Glisic S, Veljkovic N.

ScientificWorldJournal. 2013 Nov 17;2013:948617. doi: 10.1155/2013/948617. eCollection 2013.

9.

Spatial modeling of ecological areas by fitting the limiting factors for As in the vicinity of mine, Serbia.

Cakmak D, Perovic V, Saljnikov E, Jaramaz D, Sikiric B.

Environ Sci Pollut Res Int. 2014 Mar;21(5):3764-73. doi: 10.1007/s11356-013-2320-7. Epub 2013 Nov 27.

PMID:
24281676
10.

Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.

Perovic VR, Muller CP, Niman HL, Veljkovic N, Dietrich U, Tosic DD, Glisic S, Veljkovic V.

PLoS One. 2013 Apr 26;8(4):e61572. doi: 10.1371/journal.pone.0061572. Print 2013.

11.

New in silico and conventional in vitro approaches to advance HIV drug discovery and design.

Maga G, Veljkovic N, Crespan E, Spadari S, Prljic J, Perovic V, Glisic S, Veljkovic V.

Expert Opin Drug Discov. 2013 Jan;8(1):83-92. doi: 10.1517/17460441.2013.741118. Epub 2012 Nov 20. Review.

PMID:
23167743
12.

The role of long-range intermolecular interactions in discovery of new drugs.

Veljkovic N, Glisic S, Perovic V, Veljkovic V.

Expert Opin Drug Discov. 2011 Dec;6(12):1263-70. doi: 10.1517/17460441.2012.638280. Epub 2011 Nov 15.

PMID:
22647065
13.

Simple and general criterion for "in silico" screening of candidate HIV drugs.

Veljkovic N, Glisic S, Prljic J, Perovic V, Veljkovic V.

Curr Pharm Biotechnol. 2013;14(5):561-9. Review.

PMID:
22429138
14.

Genetic alterations in SMAD4 and K-ras in Serbian patients with endometrial carcinoma.

Nikolic A, Ristanovic M, Perovic V, Trifunovic J, Perovic M, Radojkovic D.

Int J Gynecol Cancer. 2012 Mar;22(3):442-6. doi: 10.1097/IGC.0b013e31823fabab.

PMID:
22266936
15.

Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1b.

Glisic S, Veljkovic N, Jovanovic Cupic S, Vasiljevic N, Prljic J, Gemovic B, Perovic V, Veljkovic V.

Protein J. 2012 Feb;31(2):129-36. doi: 10.1007/s10930-011-9381-6.

PMID:
22170451
16.

Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor.

Veljkovic V, Niman HL, Glisic S, Veljkovic N, Perovic V, Muller CP.

BMC Struct Biol. 2009 Sep 28;9:62. doi: 10.1186/1472-6807-9-62.

17.

B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.

Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stäger S.

PLoS Pathog. 2009 May;5(5):e1000431. doi: 10.1371/journal.ppat.1000431. Epub 2009 May 15.

18.

Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control.

Veljkovic V, Veljkovic N, Muller CP, Müller S, Glisic S, Perovic V, Köhler H.

BMC Struct Biol. 2009 Apr 7;9:21. doi: 10.1186/1472-6807-9-21.

19.

Theoretical assessment of phosphate amendments for stabilization of (Pb+Zn) in polluted soil.

Raicevic S, Perovic V, Zouboulis AI.

Waste Manag. 2009 May;29(5):1779-84. doi: 10.1016/j.wasman.2008.11.021. Epub 2009 Jan 9.

PMID:
19138506
20.

Discovery of new therapeutic targets by the informational spectrum method.

Veljkovic N, Glisic S, Prljic J, Perovic V, Botta M, Veljkovic V.

Curr Protein Pept Sci. 2008 Oct;9(5):493-506. Review.

PMID:
18855700
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk